to medical devices, experiments were performed using Staphylococcus aureus and a 1 three-log difference was seen compared to the control group. 2 3 Activity of WLBU2 bound to a complex polymer plastic bead through the 4 carboxyl terminus: Having assessed the activity of N-terminal coupling of WLBU2, we 5
next assessed the activity of C-terminal binding to surfaces. WLBU2 was synthetically 6 built on a polymeric plastic bead via the free carboxyl group. Analysis of the Tentagel 7 beads indicated that the substitution rate was 390 mg/g resin. As depicted in Figure 2b , 8 the WLBU2 coupled beads were able to sterilize the PA01 suspension. The 9 comparison group with Tentagel beads alone revealed no difference in the survival of P. 10 aeruginosa when compared to a media control group. This represents a five-log 11 difference in survival between the groups post exposure. 12
To determine that antimicrobial activity seen was a result of WLBU2 leeching, a 13
Transwell permeable support system was used. Tentagel-WLBU2 beads placed in the 14 upper compartment showed no difference in the growth of PA01 in the lower 15 compartment when compared to a control group without beads (Figure 2b ). Uncoupled 16
Tentagel beads in suspension with PA01 did not have an affect on the growth of PA01, 17 while the Tentagel-WLBU2 beads were able to sterilize the PA01 suspension. The 18 coupled Tentagel-WLBU2 suspension with PA01 showed a five-log difference 19 compared to the media, uncoupled and leeching control groups.
These data 20 demonstrate that physical interaction between the coupled WLBU2 and PA01 is 21 required for the antimicrobial property. It also demonstrates that the antimicrobial 22
properties are not attributable to uncoupled WLBU2. 23 Activity of WLBU2 associated to a complex a silica-calcium phosphate 24 nanocomposite associated with bone reconstruction. A novel resorbable bioactive 25 porous silica-calcium phosphate nanocomposite (SCPC) that has the ability to stimulate 1 bone regeneration and graft material resorption in vivo has been proposed 15 . WLBU2's 2 antimicrobial activity when incorporated into SCPC was evaluated. Comparison of the 3 SCPC alone versus SCPC-WLBU2 composite material was performed by adding 10 mg 4 of either of these preparations to a 1.5mL tube containing 1x10 6 P. aeruginosa strain 5 PA01 in one mL of PBS. When static incubation (i.e., no agitation) was applied to the 6 SCPC-WLBU2 minimal killing was achieved after a one hour (not shown). However, 7 when agitation was included in the protocol, the bacterial suspension was completely 8 sterilized signifying a five-log decrease in bacterial survival. This reinforces that contact 9 between the coupled WLBU2 and bacterial targets is necessary for effective killing. 10
Scanning electron microscopy (SEM) was used to visually assess these beads. Using 11 the identical bacterial suspensions, it was surprising to see that no bacteria were 12 attached to the surface of the SCPC (Figure 3a) . However, the SCPC-WLBU2 material 13 had bacteria associated to the surface even though bacterial growth was negative 14 (Figure 3b) . In data not shown, we determined that these bacteria were being lysed in 15 the composite experiment through measurement of beta-galactosidase (an intracellular 16 bacterial enzyme) released 11 . These data support our contention that the positively 17 charged peptide recruits the bacteria to the surface of the bead, resulting in the lysis of 18 the bacteria 6, 16 . 19
In the past, CAP application has been limited to a secondary role with respect to 20 their inability to demonstrate efficacy in clinical trials 6 . However in view of the current 21 antimicrobial resistance crisis, CAPs are being considered in a more creative manner 22 that circumvents their limitations. A previous report demonstrated that immobilized 23 polymyxin B binds endotoxin in vitro and in sepsis animal models in vivo 16 . This has led 24 to uses of CAP-impregnated fibers in clinical trials for the treatment of sepsis 16 . Other 25 7 applications which have been explored include the coating of urinary catheters to 1 decreased biofilm formation 17 . Polymyxin B bound to agarose beads also inhibited E. 2 coli growth in a concentration dependent curve 18 . Antibiotic loaded microspheres have 3 been attempted to provide local treatment for osteomyelitis 15, 19 . These strategies 4 reduce the exposure of CAPs to bacterial proteases 18 . We have (i) previously shown 5 that WLBU2 has greater antimicrobial activity than polymyxin B, (ii) works against a 6 broader spectrum of Gram positive and negative bacteria, and (iii) will be more effective 7 than polymyxin B 9,11 . 8
Devices such as prosthetic joints, prosthetic heart valves, cardiac pacemakers, 9
IVC and cerebrospinal fluid shunts have become essential in the medical field 13 . 10
However, these medical devices are at risk for infection and impact the rate of 11 nosocomial infections. Unlike IVC infections, most foreign body-related infections 12 require surgical removal. It is estimated that the United States averages between 13 200,000 to 400,000 catheter related infection (CRI) per year 13, 20 . In patients with long 14 term need of intravenous access, systemic as well as antibiotic lock therapy may be 15 implemented to salvage a catheter 13 . Biofilm formation on biomedical surfaces is 16 considered the basis for infection 13, 14 . Initial bacterial adherence is considered essential 17 for the formation of biofilm on catheter surfaces 13, 14 . CRIs can be difficult to treat in part 18 due to higher minimal inhibitory concentration exhibited by pathogens in the biofilm 1, 17 . 19
Reduction of biofilm formation can have a great impact in infection rates that 20
stem from prosthetics and CRI. In the past, strategies to reduce biofilm formation 21 included silver impregnated catheters; however, leaching leaves these materials 22 vulnerable to bacterial adherence. The concept of an antimicrobial peptide as a means 23 to reduce or prevent biofilm formation is feasible. The permanent covalent attachment of 24
WLBU2 to various surface while retaining its previously demonstrated antimicrobial
contact with the bacteria in order to have effective killing. As can be seen in the SEM 2 images (Figure 3b) , the bacteria are attracted to the WLBU2 coupled to the 3
Materials and Methods: 10
Preparation of bacteria. Luria broth (LB) was inoculated with a colony of P. aeruginosa 11 (strain PA01) and incubated overnight at 37ºC with shaking. The next morning, 5mL of 12 the overnight culture was transferred into 20mL of LB broth and incubated for another 2 13 hours at 37ºC with shaking. 10mL of the second incubation culture was pelleted and 14 suspended in 10mL of phosphate buffered saline (PBS) at pH of 7.8. The A 600 of the 15 suspended bacterial solution was read, and the solution was further diluted to a 16 concentration with an A 600 =0.001 in PBS. The S. aureus strain used in this study has 17 been described previously publications 3 and was prepared identically as described for 18 the P. aeruginosa strain above. to obtain a total concentration of 10µM in the suspension. A sample of the WLBU2 22 stock was separated for later comparison. The manufacturing protocol was followed 23 under aqueous conditions at room temperature for 2h. A sample of the supernatant 24 was separated and used for analysis of WLBU2 coupling. After successful attachment 1 of WLBU2 to Affigel beads (Affigel-WLBU2 beads), a 3cm column was generated. The 2 column was washed with PBS prior to running a PA01 bacterial suspension prepared as 3 described previously. The resulting suspension was plated, incubated overnight at 37ºC 4 and colony forming units (cfu) determined. followed by derivitization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate using 8
Waters AccQ·Tag analysis kit. Samples were analyzed by chromatography using 9 standard gradient conditions. Fluorescence detection at an excitation wavelength of 10 250nm was used to acquire integration peaks. 11
Binding of WLBU2 to Silica-Calcium Phosphate Nanocomposite. Resorbable porous 12 bioactive SCPC with the chemical composition was prepared by heating at 850°C. 13
Appropriate ratios of dicalcium phosphate and silicon components were placed in 14 polyethylene bottles and mixed on a roller mixer for 24h. The batch was moistened with 15 0.1 NaOH and placed in a Teflon mold. The samples were left to dry at room 16 temperatures and then thermally treated (Thermolyne 30400, Barnstead International, 17
Dubuque, IA) at 850°C for 1h. The heating temperature was selected based on the 18 differential thermal analysis results previously reported 15 . The SCPC ceramic was 19 ground, sifted and immersed in simulated body fluid at 37°C for 16h. After immersion 20 the samples were dried and the surface chemistry and morphology were analyzed by 21
Fourier transform infrared spectroscopy (FTIR) and Scanning Electron Microscope-22
Energy Dispersive X-Ray (SEM-EDX) analyses, respectively. The SCPC particles were 23 loaded with WLBU2 using immersion method 15 and dried. 24
Peptide Leaching. To evaluate potential leaching of the peptide being responsible for 1 the antimicrobial activity of the bound CAP, a Transwell protein migration system was 2 used. Bacteria was prepared as above to achieve an A 600 =0.001 in PBS. Ten 3 milligrams of Tentagel beads as well as Tentagel-WLBU2 beads were weighed 4 individually. Triplicate wells in a 96 well plate were set up by adding 600 µL of the 5 bacterial solution for all of the following groups. The first group had bacterial 6 suspension added to the lower compartment and Tentagel-WLBU2 coated beads added 7 to the upper compartment of the insert. The second group had bacterial suspension 8 added to the lower compartment and Tentagel beads placed in the upper compartment 9 of the insert. The third group had Tentagel beads to which bacterial suspension was 10 added. The fourth group had Tentagel-WLBU2 coated beads to which bacterial 11 suspension was added. Initially, the plate was rested at 37ºC, but it was there was no 12 difference between the four groups. A simple agitation was incorporated to the protocol 13 and the described results were obtained. The plate was agitated at 37ºC and each 14 group was subsequently plated to count cfu after overnight incubation at 37ºC. To asses 15 the effect of agitation a control group consisting of PA01 suspension alone was used as 16 baseline for bacterial growth. 17 
